gian carlo antonini cappellini - Oncologist - Ospedale Sandro Pertini - ASL RM2 | LinkedIn
10+ "Giancarlo Antonini" profiles | LinkedIn
Consulado General del Perú en Roma - DNI LISTOS PARA SER RECOGIDOS: ABAD CHINCHAY CESAR DIEGO ABAD CHINCHAY RUBEN EDUARDO ABAD QUIÑONES NELLY MARGARITA ABAD SALAZAR JOSE MANUEL ABANTO RAMIREZ CARLOS ALBERTO
Differential Denaturation of Serum Proteome Reveals a Significant Amount of Hidden Information in Complex Mixtures of Proteins | PLOS ONE
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma | Journal of Translational Medicine | Full Text
Untitled
Dr. Stephen B. Baylin, MD | Baltimore, MD | Endocrinologist | US News Doctors
Gian CAPPELLINI | Istituto Dermopatico dell'Immacolata, Rome | IDI | Oncologia | Research profile
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma – topic of research paper in Clinical medicine. Download scholarly article PDF
10+ "Giancarlo Antonini" profiles | LinkedIn
Investigating Serum and Tissue Expression Identified a Cytokine/Chemokine Signature as a Highly Effective Melanoma Marker
Dr. Gian Carlo Antonini Cappellini, oncologo | ClickDoc.it
Tag: Editorial Staff | The Plan
Altro: Aree non comprese e Aree specifiche derivanti da progetti specifici
Premio Roma - Albo d'oro 2019
Dr. Gian Carlo Antonini Cappellini, Oncologo a Roma | MEDICITALIA.it
Gian CAPPELLINI | Istituto Dermopatico dell'Immacolata, Rome | IDI | Oncologia | Research profile
Visual Clustering of Transcriptomic Data from Primary and Metastatic Tumors – Dependencies and Novel Pitfalls
Differential Denaturation of Serum Proteome Reveals a Significant Amount of Hidden Information in Complex Mixtures of Proteins | PLOS ONE
Giancarlo CAPPELLINI | Istituto Dermopatico dell'Immacolata, Rome | IDI | Research profile
Il caso clinico Archivi - infoMELANOMA
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma | Journal of Translational Medicine | Full Text
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma – topic of research paper in Clinical medicine. Download scholarly article PDF
Il caso clinico Archivi - infoMELANOMA
gian carlo antonini cappellini - Oncologist - Ospedale Sandro Pertini - ASL RM2 | LinkedIn
